Suchergebnisse - "Bardelli, Alberto"

PubPharm (22)

1

Long-term Clinical Outcome of Trastuzumab and Lapatinib for HER2-positive Metastatic Colorectal Cancer

enthalten in: Clinical colorectal cancer | 2020

von Tosi, F. | Sartore-Bianchi, A. | Lonardi, S. | +26

2

Pertuzumab and trastuzumab emtansine in patients with HER2-amplified metastatic colorectal cancer : the phase II HERACLES-B trial

enthalten in: ESMO open | 2020

von Sartore-Bianchi, A. | Lonardi, S. | Martino, C. | +22

3

Heterogeneity of Acquired Resistance to Anti-EGFR Monoclonal Antibodies in Patients with Metastatic Colorectal Cancer

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2017

von Pietrantonio, F. | Vernieri, C. | Siravegna, G. | +19

4

MM-151 overcomes acquired resistance to cetuximab and panitumumab in colorectal cancers harboring EGFR extracellular domain mutations

enthalten in: Science translational medicine | 2016

von Arena, S. | Siravegna, G. | Mussolin, B. | +11

CommentIn: Nat Rev Gastroenterol Hepatol. 2016 May;13(5):258-9. - PMID 27006256

5

TGFα and amphiregulin paracrine network promotes resistance to EGFR blockade in colorectal cancer cells

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2014

von Hobor, S. | Van Emburgh, B. | Crowley, E. | +3

CommentIn: Clin Cancer Res. 2014 Dec 15;20(24):6227-9. - PMID 25139340

6

Circulating pEGFR is a candidate response biomarker of cetuximab therapy in colorectal cancer

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2014

von Katsila, T. | Juliachs, M. | Gregori, J. | +7

7

Resistance to anti-EGFR therapy in colorectal cancer : from heterogeneity to convergent evolution

enthalten in: Cancer discovery | 2014

von Misale, S. | Di Nicolantonio, F. | Sartore-Bianchi, A. | +2

8

Amplification of the MET receptor drives resistance to anti-EGFR therapies in colorectal cancer

enthalten in: Cancer discovery | 2013

von Bardelli, A. | Corso, S. | Bertotti, A. | +25

9

Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer

enthalten in: Nature | 2012

von Misale, S. | Yaeger, R. | Hobor, S. | +23

CommentIn: Nat Rev Clin Oncol. 2012 Aug;9(8):428. - PMID 22733232

10

Targeting oncogenic serine/threonine-protein kinase BRAF in cancer cells inhibits angiogenesis and abrogates hypoxia

enthalten in: Proceedings of the National Academy of Sciences of the United States of America | 2012

von Bottos, A. | Martini, M. | Di Nicolantonio, F. | +6

CommentIn: Proc Natl Acad Sci U S A. 2012 May 15;109(20):E1214. - PMID 22550180